What is Biodesix, Inc.'s EV / sales?

Biodesix, Inc. (BDSX) reported EV / sales of 2× in Q1 2026.

How has Biodesix, Inc.'s EV / sales changed year-over-year?

Biodesix, Inc.'s EV / sales increased by 7.7% year-over-year, from 1.8× to 2×.

What is the long-term trend for Biodesix, Inc.'s EV / sales?

Over 5 years (2020 to 2025), Biodesix, Inc.'s EV / sales has grown at a -35.3% compound annual growth rate (CAGR), from 10.8× to 1.2×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

Biodesix, Inc. BDSX EV / sales

EV / sales at other companies

NeoGenomicsNEO

1.2×-0.2×

VeracyteVCYT

4.3×-0.4×

Adaptive BiotechnologiesADPT

7.7×+1.0×

Personalis, Inc.PSNL

9.8×+6.5×

Guardant HealthGH

11.8×+4.3×

Tempus AI, Inc.TEM

5.6×-4.6×

Other financials

Income statement

See full

Revenue$25.6M+42.3%

Operating income-$6.2M+32.1%

Net income-$7.8M+29.8%

EPS (diluted)-$0.81+46.7%

Balance sheet

See full

Cash & equivalents$25.6M+45.3%

Total debt$71.6M+15.0%

Total equity$9.1M-17.4%

Total assets$94.6M+9.7%

Cash flow

See full

Operating cash flow-$10.2M-18.2%

CapEx$81.0K+9.5%

Free cash flow-$10.2M-18.1%

Valuation

See full

Market cap$233.52M+476%

Enterprise value$279.56M+204%

P/S2.4×+1.9×

Profitability

See full

Operating margin-26%-7.5pp

Net margin-33.3%-9.3pp

FCF margin-26.8%-9.6pp

Returns & leverage

See full

Return on equity-316.5%—

Debt / equity7.8×+2.2×

Current ratio2.8×+0.6×

Where this comes from

Calculated from Biodesix, Inc.’s reported figures.

enterprise value/total revenue=2×

Based on the most recent quarter.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biodesix, Inc.'s EV / sales?: Biodesix, Inc. (BDSX) reported EV / sales of 2× in Q1 2026.
How has Biodesix, Inc.'s EV / sales changed year-over-year?: Biodesix, Inc.'s EV / sales increased by 7.7% year-over-year, from 1.8× to 2×.
What is the long-term trend for Biodesix, Inc.'s EV / sales?: Over 5 years (2020 to 2025), Biodesix, Inc.'s EV / sales has grown at a -35.3% compound annual growth rate (CAGR), from 10.8× to 1.2×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.